Edition:
United Kingdom

Sangamo Therapeutics Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

16.35USD
15 Dec 2017
Change (% chg)

$-0.05 (-0.30%)
Prev Close
$16.40
Open
$16.45
Day's High
$16.70
Day's Low
$16.05
Volume
1,669,773
Avg. Vol
375,939
52-wk High
$18.40
52-wk Low
$2.85

Select another date:

Thu, Nov 9 2017

BRIEF-Sangamo Therapeutics posts Q3 loss per share $0.15

* Sangamo Therapeutics reports third quarter 2017 financial results

BRIEF-Sangamo and Bioverativ announce FDA acceptance of IND application for ST-400

* Sangamo and Bioverativ announce FDA acceptance of IND application for ST-400 -- a gene-edited cell therapy candidate -- to treat beta-thalassemia

BRIEF-Sangamo Therapeutics reports Q2 loss per share $0.17

* Sangamo Therapeutics reports second quarter 2017 financial results

BRIEF-Sangamo Therapeutics appoints Roger Jeffs, Joseph Zakrzewski to its board

* Sangamo Therapeutics appoints Roger Jeffs, PH.D. and Joseph S. Zakrzewski to its board of directors

BRIEF-Sangamo Therapeutics announces closing of public offering of common stock

* Sangamo Therapeutics announces closing of public offering of common stock and exercise in full of underwriters' option to purchase additional shares of common stock Source text for Eikon: Further company coverage:

BRIEF-Sangamo announces pricing of $72.5 mln public offering of common stock

* Sangamo therapeutics announces pricing of $72.5 million public offering of common stock

BRIEF-Sangamo Therapeutics announces proposed public offering of common stock

* Sangamo Therapeutics announces proposed public offering of common stock Source text for Eikon: Further company coverage:

Select another date: